CONTACT
NAVARRA
+34 948 194 700
NAVARRA
×
INTRANET
PEOPLE FINDER
English
Español
WORK WITH US
INVESTOR AREA
/servlet/autocompletar/
Delete
DO YOU WANT TO HELP US?
ÚNETE A NUESTRO EQUIPO
ÁREA DE INVERSIÓN
About us
Universidad de Navarra Biomedical Campus
Research Center of the Clínica
Organization
Transparency Portal
Corporate Responsibility (Compliance)
Research
Diseases
Research divisions
Research groups
Technological platforms
Research and clinical trials
Research Staff
Human Resources Strategy for Researchers (HRS4R)
Scientific activity
Innovation
Pipeline
Patents
Entrepreneurship | Spin off
Collaboration with companies
Investor Area
Training
Cima Impulse
Training offer
Training contracts and grants
Collaborate with us
How to collaborate
Collaboration projects
Collaborating companies
Transparency
News
News
Events
Scientific Report 2024-25
Health and Science
Home
>
News
>
News
Cima Universidad de Navarra news
Specialties
Choose by department
Adhesion and Metastasis
Adoptive Cell Therapy
Adoptive Cellular Therapy
Advanced Therapies for Pediatric Solid Tumors
Advanced Therapies for Rare Liver Diseases
Animal Models
Animal Production and Experimentation
Applied and Translational Onco-Immunology
Aptámeros y Química Médica
Aptamers
Biobank
Biochemical Analysis and Cell Metabolism
Bioinformatics
Biomedical Engineering
Cancer Division
Cancer gene therapy
Cardiac Tissue Engineering
Combination Strategies for Translational Immunotherapy
Computational Biology and Translational Genomics
Cytokine-Based Therapeutics
Cytometry
DNA and RNA Medicine
Dynamics of the antitumor immune response
Enable Technologies
Epigenetics
Epilepsy
Gene Therapy for Hereditary Hearing Loss and AAV Engineering
Gene Therapy for Monogenic Encephalopathies
Gene Therapy for Rare Diseases
Gene Therapy in Neurological Diseases
Gene Therapy in Neurological Disorders
Gene Therapy in Parkinson's Disease
Gene Therapy of Renal Diseases and Study of N-terminal Acetylation of Proteins
Genomics Unit
Hemato-Oncology
Hepatology
Hepatology: Carcinogenesis and Liquid Biopsy
Hepatology: Metabolism, Epigenetics and Carcinogenesis
Hepatology: Molecular Mechanisms and Targets in liver carcinogenesis
Hepatology: Porphyrias and Carcinogenesis
Image
Immune Therapies
Immunology and Immunotherapy
Immunomodulation and Tumor Microenvironment
In vivo Organ Generation by Stem Cells
Locoregional Immunotherapy Strategies in Peritoneal Carcinomatosis
Lungsearch: Lung cancer Screening, Early detection, biomarkers and new therapeutic targets
Lymphomas
Machine Learning in Biomedicine
Medicinal Chemistry
Micro-PET
Microbiome and Clinical Physiology
Microphysiological Systems and Quantitative Biology
Morphology
Myelodysplastic Neoplasia
Myeloid Pathology
Neuroscience
Next Generation Gene Delivery Technologies
Non-coding RNA and Biotechnology
Noncoding RNA and cancer genome
Oncogenes and Effector Targets
Peptide
Physiological Control and Monitoring
Preclinical Models and Analysis Tools
Predictive Response Marker
Radioactive Facility
Radioimmunotherapy strategies for pediatric tumors
Regulación de la Expresión Génica
Renal Gene Therapy and Chimeric AAV Development
RNA and Senescence
RNA Biology and Therapy
Solid Tumor
Stress Responses and Liver Cancer Immunotherapy
Therapeutic Innovation
Therapeutic Innovation in Lung Cancer
Translational Hematology
Translational Immunomics in Hematological Neoplasms
Translational Oncology
Tumor Evasion and New Targets
Vaccine Development
Date from
Date to
A multi-omic study rules out the role of immature cells in resistance to cancer treatment
The results of this study by Cima Universidad de Navarra help improve the accuracy of diagnosis and monitoring for patients with multiple myeloma and primary systemic amyloidosis
May 26, 2026
Desarrollan una nueva herramienta bioinformática que permite diagnosticar enfermedades raras reutilizando datos genéticos ya existentes
Investigadores del Cima Universidad de Navarra confirman que UPDhmm puede detectar alteraciones genéticas ocultas y facilitar el diagnóstico de patologías
May 19, 2026
Un ensayo clínico pionero tratará de revertir el mal pronóstico de tumores cerebrales infantiles con oncovirus
Este estudio en fase 2 impulsado por el Cancer Center Clínica Universidad de Navarra pretende abrir nuevas vías terapéuticas frente a estas enfermedades sin cura y que necesitan más apoyo para la investigación
May 14, 2026
Cima at the University of Navarra has been accredited as a Severo Ochoa Center of Excellence
The Ministry of Science, Innovation, and Universities awards this recognition to Spanish institutions that stand out internationally for the significance of their research findings
May 7, 2026
Europa intensifica su estrategia de cribado del cáncer de pulmón financiando SOLACE+
La Unión Europea aprueba 7,5 millones de euros para este proyecto que busca acelerar y unificar los programas de detección precoz y en el que el Cancer Center Clínica Universidad de Navarra es el único hospital español
May 6, 2026
A New Approach to Improving Immunotherapy for Liver Cancer
Scientists at Cima Universidad de Navarra confirm that inhibiting the G9a protein with new experimental drugs improves treatment efficacy in animal models
April 28, 2026
